Mark W Koukkari, MD
Neurology · Los Altos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Koukkari’s office at (650) 254-5200 to ask if they take your plan before you enroll.
California Medical Board record
Licence G74711 · Current
Licensed to practise in California · since 1992 · expires 2028-03-31 · University of Minnesota Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$4,658
Medicare paid this office $4,658 for 12 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 11 | $1,018 | $57 |
Who their Medicare patients are
12 Original Medicare patients in 2024. Average age 37 · Under 65 100% · 85 and older 0% · Health risk score 0.63. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
The office billed $18,652, Medicare allowed $6,869 and paid $4,658; for 638 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 12 | 638 | 37 | 0.63 | $18,652 | $4,658 |
| 2023 | 11 | 325 | 35 | 0.51 | $12,187 | $2,931 |
| 2021 | 11 | 548 | 33 | 0.59 | $15,841 | $4,159 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Medicaid work
$269 in 2023
Medicaid paid $269 for 14 billed services this clinician did in 2023, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 14 | $269 |
| 2023 | 14 | 1 | 14 | $269 |
| 2022 | 12 | 1 | 12 | $895 |
See the largest Medicaid services in earlier years
2022
| Return visit (30+ min) | 12 | $895 |
Drugs they prescribed that Part D paid
$83,084
Pharmacies billed $83,084 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 179) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.
143 generic and 36 brand-name prescriptions · $83,084 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Onfi | 12 | $52,194 | $4,350 |
| Fluvoxamine Maleate | 19 | $1,589 | $84 |
| Zonisamide | 21 | $753 | $36 |
| Lamotrigine | 13 | $446 | $34 |
| Risperidone | 18 | $434 | $24 |
See all 7 drugs
| Onfi | 12 | $52,194 | $4,350 |
| Fluvoxamine Maleate | 19 | $1,589 | $84 |
| Zonisamide | 21 | $753 | $36 |
| Lamotrigine | 13 | $446 | $34 |
| Risperidone | 18 | $434 | $24 |
| Clonazepam | 14 | $262 | $19 |
| Clonidine | 13 | $103 | $8 |
Year by year
| 2024 | 179 | 17 | 0% (0) | 20% | $83,084 |
| 2023 | 186 | 13 | 0% (0) | 22% | $108,442 |
| 2022 | 170 | None | 0% (0) | 24% | $99,030 |
| 2021 | 200 | 12 | 0% (0) | 20% | $86,675 |
| 2020 | 170 | 11 | 0% (0) | 21% | $89,749 |
| 2019 | 120 | None | 0% (0) | 20% | $72,166 |
| 2018 | 75 | None | 0% (0) | 32% | $64,863 |
| 2017 | 72 | None | 0% (0) | 47% | $63,679 |
| 2016 | 80 | None | 0% (0) | 53% | $55,043 |
| 2015 | 61 | None | 0% (0) | 59% | $46,311 |
| 2014 | 53 | None | 0% (0) | 57% | $35,154 |
| 2013 | 53 | None | 0% (0) | 51% | $35,125 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Onfi | 12 | $53,426 | $4,452 |
| Lacosamide | 12 | $7,320 | $610 |
| Zonisamide | 23 | $1,316 | $57 |
| Fluvoxamine Maleate | 27 | $1,309 | $48 |
| Risperidone | 24 | $956 | $40 |
| Clonazepam | 18 | $253 | $14 |
| Clonidine | 13 | $73 | $6 |
2022: 7 drugs
| Onfi | 12 | $49,241 | $4,103 |
| Fluvoxamine Maleate | 24 | $1,550 | $65 |
| Risperidone | 24 | $291 | $12 |
| Lamotrigine | 11 | $267 | $24 |
| Clonazepam | 16 | $198 | $12 |
| Topiramate | 11 | $42 | $4 |
| Lorazepam | 12 | $5 | $0 |
2021: 9 drugs
| Onfi | 12 | $45,855 | $3,821 |
| Aripiprazole | 13 | $4,590 | $353 |
| Fluvoxamine Maleate | 24 | $1,266 | $53 |
| Zonisamide | 15 | $445 | $30 |
| Risperidone | 24 | $343 | $14 |
| Clonazepam | 17 | $189 | $11 |
| Trazodone | 19 | $163 | $9 |
| Topiramate | 15 | $50 | $3 |
| Lorazepam | 12 | $12 | $1 |
2020: 10 drugs
| Onfi | 12 | $40,925 | $3,410 |
| Aripiprazole | 14 | $7,403 | $529 |
| Atomoxetine | 12 | $4,164 | $347 |
| Fluvoxamine Maleate | 22 | $1,137 | $52 |
| Risperidone | 23 | $309 | $13 |
| Clonazepam | 15 | $280 | $19 |
| Trazodone | 12 | $124 | $10 |
| Citalopram Hbr | 12 | $59 | $5 |
| Lorazepam | 11 | $38 | $3 |
| Sertraline | 12 | $30 | $3 |
2019: 7 drugs
| Onfi | 12 | $36,506 | $3,042 |
| Fluvoxamine Maleate | 11 | $445 | $40 |
| Risperidone | 12 | $234 | $19 |
| Lamotrigine | 17 | $224 | $13 |
| Trazodone | 12 | $122 | $10 |
| Clonazepam | 15 | $91 | $6 |
| Sertraline | 12 | $58 | $5 |
2018: 4 drugs
| Onfi | 12 | $29,920 | $2,493 |
| Lamotrigine | 12 | $379 | $32 |
| Fluvoxamine Maleate | 12 | $355 | $30 |
| Clonazepam | 12 | $83 | $7 |
2017: 5 drugs
| Onfi | 12 | $26,107 | $2,176 |
| Fluvoxamine Maleate | 13 | $369 | $28 |
| Lamotrigine | 12 | $325 | $27 |
| Clonazepam | 12 | $89 | $7 |
| Sertraline | 13 | $39 | $3 |
2016: 5 drugs
| Lamictal | 12 | $28,940 | $2,412 |
| Onfi | 22 | $24,934 | $1,133 |
| Lamotrigine | 12 | $360 | $30 |
| Clonazepam | 11 | $58 | $5 |
| Sertraline | 13 | $34 | $3 |
2015: 3 drugs
| Onfi | 27 | $25,575 | $947 |
| Lamotrigine | 13 | $425 | $33 |
| Sertraline | 11 | $33 | $3 |
2014: 3 drugs
| Onfi | 21 | $14,827 | $706 |
| Lamotrigine | 12 | $473 | $39 |
| Sertraline | 11 | $68 | $6 |
2013: 4 drugs
| Lamictal | 11 | $21,304 | $1,937 |
| Onfi | 14 | $12,118 | $866 |
| Lamotrigine | 11 | $598 | $54 |
| Sertraline | 13 | $80 | $6 |
Money from drug and device companies
$13 in 2021
A payment is not proof that care is biased.
| Zogenix | Fintepla | $13 | 1 payment
|
See the published payment
| Zogenix | Education · 2021-12-08 | Fintepla | $13 |
Professional record
- NPI
- 1750479929
- Licence
- CA G74711California G74711: Current · expires 2028-03-31
- Trained
- University of Minnesota Medical School, 1990
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2084N0402X (2084N0402X); Federal specialty code 174400000X (174400000X); Neurology (2084N0400X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-10-11
- NPI last updated
- 2016-03-22
This is when the NPI record was last certified, not a medical board exam.